D. Western Therapeutics Institute: Announcements of individual stocks: Notification of Receipt of Approval Notification for Neurological Pain Treatment Drug, DW-5LBT.
D. Western Therapeutics Institute: Change Report
D. Western Therapeutics Institute: Announcement of the mass exercise of the 12th subscription rights (with exercise price adjustment clause).
D. Western Therapeutics Institute: Announcements of monthly exercise status for the 12th subscription rights (with exercise price adjustment clause).
D. Western Therapeutics Institute: Change report.
D. Western Therapeutics Institute: Announcement of completion of acquisition and extinguishment of subscription rights for the 11th time.
D. Western Therapeutics Institute: Change Report (short-term mass transfer)
D. Western Therapeutics Institute: Interim report
D. Western Therapeutics Institute: Announcements of individual stocks regarding the completion of redemption of the first series of unsecured convertible bonds with subscription rights and the recording of special losses.
D. Western Therapeutics Institute: Report on a large shareholding
D. Western Therapeutics Institute: Notice regarding completion of payments relating to the issuance of unsecured corporate bonds (private placement bonds) and 12th stock acquisition rights (with exercise price correction clauses) through third-party allotment
D.WESTERN THERAPEUTICS INST: Notice regarding the redemption of the 1st unsecured convertible bonds with stock acquisition rights, the 11th acquisition and cancellation of stock acquisition rights, and the issuance of unsecured corporate bonds and the 12th stock acquisition rights through third party allotment
D.WESTERN THERAPEUTICS INST: Q&A on the issuance of unsecured corporate bonds and the 12th Stock Acquisition Rights
D.WESTERN THERAPEUTICS INST: Securities registration form (built-in method)
D.WESTERN THERAPEUTICS INST: Confirmation letter
D.WESTERN THERAPEUTICS INST: Quarterly Report - 27th Quarter 1 (2024/01/01 to 2024/03/31)
D.WESTERN THERAPEUTICS INST: Consolidated financial results for the three months ended 2024/3/31 (based on Japanese accounting standards)
D.WESTERN THERAPEUTICS INST: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [Japanese GAAP] (consolidated)
D.WESTERN THERAPEUTICS INST: Notice regarding completion of payment of the issuance of new shares as a stock reward with transfer restrictions
D.WESTERN THERAPEUTICS INST: Notice Concerning Issuance of New Shares as Stock Compensation with Transfer Restricted Shares
No Data